Novavax (NASDAQ: NVAX) is one of the world’s leading biotechnology companies, and its share price has risen by an impressive 82% in the last six months. After its 23% rally in the last 5 days, a large number of investors are trying to find out all they can about the company.
This article details everything you need to know before you invest in Novavax stock. We explain what Novavax is, what it does and how it makes money, and what its potential is as an investment. In addition, our analysts have provided their NVAX price forecast to help you understand the value proposition that is on offer.
For those of you who want to jump ahead of the queue and buy Novavax shares immediately, we can help. Just scroll down to the section below and check out the two best places to buy, sell and trade NVAX stock in the UK and elsewhere.
How & where to buy Novavax stock online
To buy NVAX shares, click on one of the two links below, sign up, deposit funds into your account and purchase the number of shares you want to speculate on.
So, without further ado, here is our list of the two best platforms to buy and sell Novavax shares right now:
eToro is one of the world's leading multi-asset trading platforms offering some of the lowest commission and fee rates in the industry. It's social copy trading features make it a great choice for those getting started.
Financial company driven by technology and offering all-in-one self-directed investment platform that provides excellent user experience.
What is Novavax (NVAX)?
Incorporated in 1987 and headquartered in Gaithersburg, Maryland, it is a biotechnology company that focusses on the discovery, development, and commercialisation of vaccines to prevent serious infectious diseases and address health needs.
Novavax has a whole host of vaccine candidates, but perhaps its most well known is NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials.
The company’s share price has surged following a wider trend amongst the COVID-19 vaccine developers and producers as there are mounting fears of a resurgence of the disease.
Should I buy Novavax stock?
If you think NVAX’s COVID-19 vaccine – or one of its many other candidates – can achieve commercial success, investing now ahead of growth could be a risky but promising move.
Novavax price target 2021
Our NVAX price target is as follows: a 12-month high of $294, with a median of $272 and a low of $161.